# RECORNA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/recorna

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.recornabio.com/
- Latest round: Angel (Jun 28, 2024)
- Investors on record: 7

## About

Based in Guangzhou, China, and founded in 2021, RECORNA is a drug company that focuses on developing targeted RNA editing technology. The R&D center has been set up in the US. The company was awarded Best Enterprise of Innovative Pharmaceuticals in 2023 and the Second Prize in the Fifth Guangzhou Women. In June 2024, it closed an angel+ funding. In April 2025, RECORNA raised an undisclosed amount of venture funding from new investors Huangpu Biomedical Investment and Oriental Fortune Capital. The company specializes in developing innovative drugs through targeted RNA editing technologies for cardiovascular and cerebrovascular diseases, neurological diseases, respiratory diseases, and other areas. It has established R&D platforms, including drug discovery, biological validation, delivery system development, etc. The company generates revenue by providing research and development services for RNA editing technology.

## Funding rounds

- Angel, Jun 28, 2024 — Tiantu Capital, BeiGene Ltd., Hangzhou Xiaochi Private Equity Fund Management, Yael Capital, Beijing Life Science Park Innovation Investment Fund
- Angel, May 23, 2022 — Yinxinggu Capital, Zhongguancun Development Venture, Hangzhou Xiaochi Private Equity Fund Management

## Investors

- Yinxinggu Capital (https://capitalatlas.ai/funds/yinxinggu-capital) — Angel
- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Angel
- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Angel
- Tiantu Capital (https://capitalatlas.ai/funds/tiantu-capital) — Angel
- BeiGene Ltd. — Angel
- Yael Capital (https://capitalatlas.ai/funds/yael-capital) — Angel
- Beijing Life Science Park Innovation Investment Fund — Angel